Expression of the developmental Sonic hedgehog (Shh) signalling pathway is up‐regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes
暂无分享,去创建一个
C. Haslett | J. Lamb | D. Harrison | S. Howie | G. A. Stewart | G. Hoyne | W. Wallace | E. Jarman | S. Ahmad | G. Stewart
[1] Takayuki Asahara,et al. The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors , 2001, Nature Medicine.
[2] D. Donoghue,et al. Patched1 interacts with cyclin B1 to regulate cell cycle progression , 2001, The EMBO journal.
[3] D. Baker,et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation , 2001, Nature Immunology.
[4] T. Hartman,et al. Smoking-related interstitial lung diseases: a concise review. , 2001, The European respiratory journal.
[5] A. Nicholson,et al. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. , 2000, American journal of respiratory and critical care medicine.
[6] T. Steele,et al. Erythroid differentiation in vitro is blocked by cyclopamine, an inhibitor of hedgehog signaling. , 2000, Blood cells, molecules & diseases.
[7] A. Varas,et al. Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte. , 2000, Immunity.
[8] N. Kaminski,et al. TGF-β1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3ε mAb- and CD28 mAb-activated splenocytes and thymocytes , 2000 .
[9] D. Rockey,et al. Expression of the Integrin α8β1 during Pulmonary and Hepatic Fibrosis , 2000 .
[10] J. Orenstein,et al. TGF-β influences the life and death decisions of T lymphocytes , 2000 .
[11] J. Letterio. Murine models define the role of TGF-beta as a master regulator of immune cell function. , 2000, Cytokine & growth factor reviews.
[12] David Warburton,et al. The molecular basis of lung morphogenesis , 2000, Mechanisms of Development.
[13] S. Levanat,et al. Involvement of PTCH gene in various noninflammatory cysts , 2000, Journal of Molecular Medicine.
[14] N. Kaminski,et al. TGF-beta 1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes. , 2000, Immunopharmacology.
[15] J. Orenstein,et al. TGF-beta influences the life and death decisions of T lymphocytes. , 2000, Cytokine & growth factor reviews.
[16] A. Cerwenka,et al. TGF-β1: immunosuppressant and viability factor for T lymphocytes , 1999 .
[17] Paul A. Khavari,et al. Sonic Hedgehog Opposes Epithelial Cell Cycle Arrest , 1999, The Journal of cell biology.
[18] J. Rae,et al. Electrically silent potassium channel subunits from human lens epithelium. , 1999, American journal of physiology. Cell physiology.
[19] D. Warburton,et al. Adenovirus-mediated decorin gene transfer prevents TGF-beta-induced inhibition of lung morphogenesis. , 1999, The American journal of physiology.
[20] H. Kiyosawa,et al. Expression of sonic hedgehog signal transducers, patched and smoothened, in human basal cell carcinoma , 1999, Pathology international.
[21] A. Cerwenka,et al. TGF-beta1: immunosuppressant and viability factor for T lymphocytes. , 1999, Microbes and infection.
[22] P. Sime,et al. Transforming growth factor-beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis. , 1999, Current topics in pathology. Ergebnisse der Pathologie.
[23] A. McMahon,et al. Sonic hedgehog regulates branching morphogenesis in the mammalian lung , 1998, Current Biology.
[24] M. Post,et al. Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus , 1998, Nature Genetics.
[25] B. Hogan,et al. Epithelial/mesenchymal interactions and branching morphogenesis of the lung. , 1998, Current opinion in genetics & development.
[26] A. Mann,et al. Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. , 1998, The European respiratory journal.
[27] M. Parisi,et al. The role of the hedgehog/patched signaling pathway in epithelial stem cell proliferation: from fly to human , 1998, Cell Research.
[28] D. Warburton,et al. Epithelium-specific adenoviral transfer of a dominant-negative mutant TGF-β type II receptor stimulates embryonic lung branching morphogenesis in culture and potentiates EGF and PDGF-AA , 1998, Mechanisms of Development.
[29] Q. Gu,et al. Activating Smoothened mutations in sporadic basal-cell carcinoma , 1998, Nature.
[30] D. Warburton,et al. Commitment and differentiation of lung cell lineages. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[31] M. Scott,et al. Basal cell carcinomas in mice overexpressing sonic hedgehog. , 1997, Science.
[32] Paul A. Khavari,et al. Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog , 1997, Nature Medicine.
[33] Andrew P. McMahon,et al. The world according to bedgebog , 1997 .
[34] R. D. du Bois,et al. Interstitial lung disease: basic mechanisms and genetic predisposition. , 1997, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[35] B. Hogan,et al. Branching morphogenesis of the lung: new models for a classical problem. , 1997, Cold Spring Harbor symposia on quantitative biology.
[36] A. McMahon,et al. The world according to hedgehog. , 1997, Trends in genetics : TIG.
[37] B. Hogan,et al. Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. , 1997, Development.
[38] D. Warburton,et al. Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture. , 1996, Developmental biology.
[39] R. Tuder. A pathologist's approach to interstitial lung disease , 1996, Current opinion in pulmonary medicine.
[40] G. Haroske,et al. Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. , 1996, Histology and histopathology.
[41] D. Lamb,et al. THE IMMUNOLOGICAL ARCHITECTURE OF B‐LYMPHOCYTE AGGREGATES IN CRYPTOGENIC FIBROSING ALVEOLITIS , 1996, The Journal of pathology.
[42] K. Flanders,et al. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. , 1996, American journal of respiratory cell and molecular biology.
[43] M. Selman,et al. Increased expression of intercellular adhesion molecule 1, CD11/CD18 cell surface adhesion glycoproteins and alpha 4 beta 1 integrin in a rat model of chronic interstitial lung fibrosis. , 1996, Pathobiology : journal of immunopathology, molecular and cellular biology.
[44] D. Lamb,et al. A type 2 (Th2‐like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA) , 1995, Clinical and experimental immunology.
[45] D. Lamb,et al. A novel model for human interstitial lung disease: Hapten‐driven lung fibrosis in rodents , 1995, The Journal of pathology.
[46] D. Lamb,et al. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis , 1995, The Journal of pathology.
[47] D. Lamb,et al. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. , 1994, Thorax.
[48] H. Moses,et al. TGF beta 1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures. , 1994, Development.
[49] D. Lamb,et al. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. , 1994, Thorax.
[50] S. Young,et al. Tenascin-C in rat lung: distribution, ontogeny and role in branching morphogenesis. , 1994, Developmental biology.
[51] B. Corrin,et al. Immunohistochemical localization of transforming growth factor‐β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders , 1994, Histopathology.
[52] M. Turner‐Warwick. Interstitial lung disease of unknown etiology. , 1991, Chest.
[53] M. Warwick. SymposiumInterstitial Lung Disease of Unknown Etiology , 1991 .
[54] J. McDonald,et al. Potential role of RGD-binding integrins in mammalian lung branching morphogenesis. , 1991, Development.
[55] M. Sporn,et al. Colocalization of TGF-beta 1 and collagen I and III, fibronectin and glycosaminoglycans during lung branching morphogenesis. , 1990, Development.
[56] T. King,et al. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. , 1989, The American review of respiratory disease.
[57] E. Chen,et al. The murine transforming growth factor-beta precursor. , 1986, The Journal of biological chemistry.
[58] J. Last,et al. Early cellular events in pulmonary fibrosis. , 1986, Experimental lung research.
[59] R. Crystal,et al. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. , 1984, The New England journal of medicine.